Statin use at cancer diagnosis linked to lower mortality

November 8, 2012
Statin use at cancer diagnosis linked to lower mortality
For patients with cancer, statin use prior to diagnosis correlates with reduced all-cause and cancer-related mortality, according to a study published in the Nov. 8 issue of the New England Journal of Medicine.

(HealthDay)—For patients with cancer, statin use prior to diagnosis correlates with reduced all-cause and cancer-related mortality, according to a study published in the Nov. 8 issue of the New England Journal of Medicine.

In an effort to examine whether statin use initiated before reduced cancer-related mortality, Sune F. Nielsen, Ph.D., from Copenhagen University Hospital in Denmark, and colleagues evaluated mortality among patients from the Danish population who had received a diagnosis of cancer between 1995 and 2007 and were followed up through December 2009. The cohort included 18,271 patients aged 40 or older who had used statins regularly before diagnosis, and 277,204 patients who had never used statins.

The researchers found that, compared with non-users, for statin users the multivariable-adjusted hazard ratios were significantly lower and were 0.85 each for death from any cause and death from cancer. The adjusted hazard ratios for all-cause mortality varied according to the defined daily dose of statin per day and were 0.82 for a dose of 0.01 to 0.75; 0.87 for a dose of 0.76 to 1.50; and 0.87 for a dose higher than 1.50. The corresponding hazard ratios for cancer-related mortality were 0.83, 0.87, and 0.87, respectively. For each of 13 there was reduced cancer-related mortality for statin users versus non-users.

"In conclusion, among patients with cancer, we observed an association between statin use at the time of diagnosis and a reduced risk of cancer-related mortality, with a reduction of up to 15 percent," the authors write. "Prospective evaluation of the hypothesis that statin use prolongs the survival of patients with cancer is needed."

One author disclosed to the .

Explore further: Post-SES implantation, statins prevent late revascularization

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Post-SES implantation, statins prevent late revascularization

May 12, 2012
(HealthDay) -- For patients who undergo sirolimus-eluting stent (SES) implantation, use of statin therapy is associated with a reduced risk of late target lesion revascularization (TLR), according to a study published in ...

Study finds no link between statins and cancer risk

July 25, 2011
(Medical Xpress) -- A new study published in the Journal of the American College of Cardiology reports that, contrary to previous studies, the use of cholesterol reducing statin drugs does not increase the risk of patients ...

Statins may help prolong survival in NSCLC resection

October 22, 2012
Patients who have undergone resection for non-small cell lung cancer (NSCLC) may improve their overall survival and reduce the risk of recurrence by taking statins.

Statins prevent cancer in heart transplant recipients

May 20, 2012
Statins prevent cancer and reduce death from all causes in heart transplant recipients. The findings were independent of cholesterol levels.

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

1 / 5 (1) Nov 09, 2012
Let us try to manufacture another bogus reason to continue to sell statins.

Billions of dollars are at stake.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.